Zydus Cadila Has Received Final Approval From The Us Food And Drug Administration (Fda) To Market Glycopyrrolate Injection In The Strengths Of 0.2 Mg/Ml And 0.4 Mg/2 Ml (0.2 Mg/Ml) Single-Dose Vials And 1 Mg/5 Ml (0.2 Mg/Ml) And 4 Mg/20 Ml (0.2 Mg/Ml) Multiple-Dose Vials, (Us Rld: Robinul). Glycopyrrolate Is Used Before Surgery To Decrease The Volume Of Secretions From Mouth, Lungs And Stomach. It Can Also Be Used Either Before Or During Surgery To Maintain Heart
